Women and HIV in British Columbia

Women make up approximately 18% of the population living with HIV in British Columbia. Women living with HIV can face unique barriers to care and challenges adhering to antiretroviral therapy (ART), compared with men. As a result, women often are not fully benefitting from the life-saving treatment available to them. In this issue of the HIV Pulse, we report on women living with HIV in British Columbia, using data from recent BC-CfE publications, the Provincial Quarterly Monitoring Reports and the BCCDC 2014 HIV Annual Report.

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025